Abstract Details

Title Cognitive Evolution in Tysabri (natalizumab)-Treated Multiple Sclerosis Patients

Topic Multiple Sclerosis

Presentation(s) (-)

Poster/Presentation
Number 171

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Francois H. Jacques, MD (Clinique Neuro-Outaouais) PRESENTER	No disclosure on file
Brian Harel, PhD	Brian Harel, PhD has received personal compensation for serving as an employee of Takeda. An immediate family member of Brian Harel, PhD has received personal compensation for serving as an employee of Astra Zeneca. Brian Harel, PhD has or had stock in Takeda, Merck, Day One Biopharmaceuticals. An immediate family member of Brian Harel, PhD has or had stock in Eli Lilly, Pfizer, Astra Zeneca.Brian Harel, PhD has or had stock in Cogstate.
	No disclosure on file
	No disclosure on file
	No disclosure on file